Compare SNO vs RSNA
| 7.0 SNO | 10.0 RSNA | |
|---|---|---|
| Score | ||
| Buzzbox Score | 7.0 (Strong) | 10.0 (Exceptional) |
| Event Details | ||
| Dates | November 12-15, 2026 | November 29 - December 3, 2026 |
| Location | Pennsylvania Convention Center, Philadelphia, PA | Chicago, IL (McCormick Place) |
| Scale | mid | mega |
| Audience | ||
| Attendees | 3,000 | 38,000 |
| Exhibitors | n/a | 650 |
| Purchasing authority | ~55% | ~78% |
| Effective buyers | 1,650 | 29,640 |
| Costs | ||
| $/sqft | n/a | $41.25 |
| 10×10 space | n/a | $4,125 |
| All-in estimate | n/a | n/a |
| Cost per buyer | n/a | n/a |
Why exhibit at SNO
SNO concentrates the entire brain tumor treatment community in one room, neurosurgeons, radiation oncologists, medical oncologists, and researchers. If you have a device or therapy used in neuro-oncology, there is no more targeted audience. The convention center venue in Philadelphia allows proper exhibit builds.
Why exhibit at RSNA
Largest radiology gathering in the world. Essential for imaging equipment, contrast media, AI/digital health in radiology, and radiation protection vendors. Decision-makers come to see and touch new tech.
Why skip SNO
Extremely narrow audience: if your product is not directly used in brain/CNS tumor treatment, this is not your show. The meeting is heavily science and pharma-driven, so pure device companies may feel out of place. Limited to ~3,000 attendees, so volume is modest. Pricing is not publicly listed.
Why skip RSNA
Wrong audience for non-imaging device companies. Booth costs are brutal for first-timers.
Long-term partners
INFAB (10+ years) • AAGL (8+ years) • True Digital Surgery